The variability of volatile organic compounds in the indoor air of clinical environments
Open Access
- 2 December 2021
- journal article
- research article
- Published by IOP Publishing in Journal of Breath Research
- Vol. 16 (1) , 016005
Abstract
The development of clinical breath-analysis is confounded by the variability of background volatile organic compounds (VOCs). Reliable interpretation of clinical breath-analysis at individual, and cohort levels requires characterisation of clinical-VOC levels and exposures. Active-sampling with thermal-desorption/gas chromatography-mass spectrometry recorded and evaluated VOC concentrations in 245 samples of indoor air from three sites in a large National Health Service (NHS) provider trust in the UK over 27 months. Data deconvolution, alignment and clustering isolated 7344 features attributable to VOC and described the variability (composition and concentration) of respirable clinical VOC. 328 VOC were observed in more than 5% of the samples and 68 VOC appeared in more than 30% of samples. Common VOC were associated with exogenous and endogenous sources and 17 VOC were identified as seasonal differentiators. The presence of metabolites from the anaesthetic sevoflurane, and putative-disease biomarkers in room air, indicated that exhaled VOC were a source of background-pollution in clinical breath-testing activity. With the exception of solvents, and waxes associated with personal protective equipment (PPE), exhaled VOC concentrations above 3 µg m−3 are unlikely to arise from room air contamination, and in the absence of extensive survey-data, this level could be applied as a threshold for inclusion in studies, removing a potential environmental confounding-factor in developing breath-based diagnostics.Keywords
All Related Versions
Funding Information
- Midlands Asthma and Allergy Research Association (MAARA) And British Lung Foundation (BLFPHD17-1)
- Medical Research Council (MRC), Engineering and Physical Sciences Research Council (Research Council (EPSRC) Stratified Medicine Grant)
This publication has 39 references indexed in Scilit:
- Post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite in exhaled breath: pharmacokinetic models for assessing liver functionJournal of Breath Research, 2013
- Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confoundersJournal of Breath Research, 2013
- Application of ’omics technologies to biomarker discovery in inflammatory lung diseasesEuropean Respiratory Journal, 2013
- The versatile use of exhaled volatile organic compounds in human health and diseaseJournal of Breath Research, 2012
- Variation in the levels of volatile trace gases within three hospital environments: implications for clinical breath testingJournal of Breath Research, 2010
- Breath air analysis and its use as a biomarker in biological monitoring of occupational and environmental exposure to chemical agentsJournal of Chromatography B, 2007
- Impact of inspired substance concentrations on the results of breath analysis in mechanically ventilated patientsBiomarkers, 2005
- Degradation products of Tenax TA formed during sampling and thermal desorption analysis: Indicators of reactive species indoorsAtmospheric Environment, 1997
- Metabolic and environmental origins of volatile organic compounds in breath.Journal of Clinical Pathology, 1994
- Occupational Exposure Monitoring Using Breath AnalysisJournal of Occupational and Environmental Medicine, 1986